Varenicline in the treatment of tobacco dependence
Karl Fagerström1, John Hughes21Smokers Information Centre, Fagerström Consulting AB, Berga Alle 1, 25452 Helsingborg, Sweden; 2University of Vermont, Burlington, Vermont, USAAbstract: Varenicline, a partial agonist of α4β2 nicotinic acetylcholine...
Guardado en:
Autores principales: | Karl Fagerström, John Hughes |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://doaj.org/article/67507169e94a4f73a9289c9ce39e4f48 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Varenicline improves motor and cognitive symptoms in early Huntington’s disease
por: McGregor AL, et al.
Publicado: (2016) -
Daytime sleepiness in elderly Parkinson’s disease patients and treatment with the psychostimulant modafinil: A preliminary study
por: Johan Lökk
Publicado: (2010) -
Increasing dependency of older people in nursing homes is associated with need for dental treatments
por: Zenthöfer A, et al.
Publicado: (2014) -
Review of teriflunomide and its potential in the treatment of multiple sclerosis
por: Clemens Warnke, et al.
Publicado: (2009) -
Parkinson’s disease patients’ subjective descriptions of characteristics of chronic pain, sleeping patterns and health-related quality of life
por: Skogar Ö, et al.
Publicado: (2012)